Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Warren

Showing results (71-80 of 256) with videos related to

Pageof 26
Sort By:
The British Journal of Dermatology|March 15, 2022
A rapid access clinic for psoriasis: first experiencesClaire Reid, Charlotte Welsh, Holly Martin-Smith, et al.
The British Journal of Dermatology|May 22, 2024
Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort studyMonika Frysz, Smit Patel, Marie Oy Yee Li, et al.
American Journal of Clinical Dermatology|May 26, 2017
Erratum to: Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE StudyCarle Paul, Craig Leonardi, Alan Menter, et al.
The Journal of Investigative Dermatology|August 28, 2017
Research Techniques Made Simple: Bioinformatics for Genome-Scale BiologyAmy C Foulkes, David S Watson, Christopher E M Griffiths, et al.
Acta Dermato-Venereologica|June 17, 2026
Atopic Dermatitis Across the Lifespan: Understanding, Measuring and Minimizing Cumulative Life Course ImpairmentMatthias Augustin, Paolo Amerio, Anthony Bewley, et al.
American Journal of Clinical Dermatology|February 26, 2017
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE StudyCarle Paul, Craig Leonardi, Alan Menter, et al.
Advances in Therapy|March 22, 2022
Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe PsoriasisCraig L Leonardi, Kyoungah See, Russel Burge, et al.
Advances in Therapy|September 2, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b TrialAlice B Gottlieb, Richard B Warren, Matthias Augustin, et al.
Dermatology and Therapy|November 1, 2024
Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysisRichard B Warren, Kerry Donnelly, Sandeep Kiri, et al.
Dermatology and Therapy|July 14, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 TrialsRichard B Warren, Alice B Gottlieb, Joseph F Merola, et al.
Pageof 26

Showing results (71-80 of 256) with videos related to

Sort By:
Pageof 26
The British Journal of Dermatology|March 15, 2022
A rapid access clinic for psoriasis: first experiencesClaire Reid, Charlotte Welsh, Holly Martin-Smith, et al.
The British Journal of Dermatology|May 22, 2024
Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort studyMonika Frysz, Smit Patel, Marie Oy Yee Li, et al.
American Journal of Clinical Dermatology|May 26, 2017
Erratum to: Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE StudyCarle Paul, Craig Leonardi, Alan Menter, et al.
The Journal of Investigative Dermatology|August 28, 2017
Research Techniques Made Simple: Bioinformatics for Genome-Scale BiologyAmy C Foulkes, David S Watson, Christopher E M Griffiths, et al.
Acta Dermato-Venereologica|June 17, 2026
Atopic Dermatitis Across the Lifespan: Understanding, Measuring and Minimizing Cumulative Life Course ImpairmentMatthias Augustin, Paolo Amerio, Anthony Bewley, et al.
American Journal of Clinical Dermatology|February 26, 2017
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE StudyCarle Paul, Craig Leonardi, Alan Menter, et al.
Advances in Therapy|March 22, 2022
Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe PsoriasisCraig L Leonardi, Kyoungah See, Russel Burge, et al.
Advances in Therapy|September 2, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b TrialAlice B Gottlieb, Richard B Warren, Matthias Augustin, et al.
Dermatology and Therapy|November 1, 2024
Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysisRichard B Warren, Kerry Donnelly, Sandeep Kiri, et al.
Dermatology and Therapy|July 14, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 TrialsRichard B Warren, Alice B Gottlieb, Joseph F Merola, et al.
Pageof 26